Citadel Advisors - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 152 filers reported holding KURA ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$13,557,719
-34.2%
1,486,592
-23.7%
0.00%
-25.0%
Q2 2023$20,612,115
-13.2%
1,948,215
+0.4%
0.00%
-20.0%
Q1 2023$23,742,185
+155.0%
1,941,307
+158.8%
0.01%
+150.0%
Q4 2022$9,310,726
+66.6%
750,260
+83.3%
0.00%
+100.0%
Q3 2022$5,590,000
+72.0%
409,266
+130.8%
0.00%0.0%
Q2 2022$3,250,000
-6.3%
177,334
-17.8%
0.00%0.0%
Q1 2022$3,467,000
-32.8%
215,633
-41.5%
0.00%0.0%
Q4 2021$5,163,000
+65.5%
368,750
+121.4%
0.00%0.0%
Q3 2021$3,120,000
+129.7%
166,558
+155.8%
0.00%
Q2 2021$1,358,000
-96.7%
65,105
-95.5%
0.00%
-100.0%
Q1 2021$41,278,000
-59.7%
1,460,117
-53.5%
0.01%
-61.5%
Q4 2020$102,498,000
+54.5%
3,138,313
+44.9%
0.03%
+36.8%
Q3 2020$66,354,000
+300.9%
2,165,586
+113.3%
0.02%
+216.7%
Q2 2020$16,552,000
+168.4%
1,015,382
+63.8%
0.01%
+100.0%
Q1 2020$6,168,000
+549.3%
619,954
+797.1%
0.00%
Q4 2019$950,000
+314.8%
69,105
+357.1%
0.00%
Q3 2019$229,000
-96.1%
15,118
-95.0%
0.00%
-100.0%
Q2 2019$5,940,000
+991.9%
301,686
+677.7%
0.00%
Q4 2018$544,000
+11.7%
38,792
+39.4%
0.00%
Q3 2018$487,000
+4.1%
27,831
+8.3%
0.00%
Q2 2018$468,00025,7080.00%
Other shareholders
KURA ONCOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,807,982$59,049,0006.41%
ACUTA CAPITAL PARTNERS, LLC 637,500$20,821,0005.67%
Asymmetry Capital Management, L.P. 346,518$11,317,0005.16%
Affinity Asset Advisors, LLC 260,000$8,492,0004.50%
EcoR1 Capital, LLC 1,773,037$57,907,0003.11%
VR Adviser, LLC 575,000$18,780,0002.76%
COMMODORE CAPITAL LP 133,503$4,360,0002.37%
Ghost Tree Capital, LLC 325,000$10,615,0002.36%
Avoro Capital Advisors LLC 4,000,000$130,640,0002.25%
SILVERARC CAPITAL MANAGEMENT, LLC 90,000$2,939,0001.71%
View complete list of KURA ONCOLOGY INC shareholders